Empowering human cardiac progenitor cells by P2Y(14) nucleotide receptor overexpression

KEY POINTS: Autologous cardiac progenitor cell (CPC) therapy is a promising approach for treatment of heart failure (HF). There is an unmet need to identify inherent deficits in aged/diseased human CPCs (hCPCs) derived from HF patients in the attempts to augment their regenerative capacity prior to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Physiol
Main Authors: Khalafalla, Farid G., Kayani, Waqas, Kassab, Arwa, Ilves, Kelli, Monsanto, Megan M., Alvarez, Roberto, Chavarria, Monica, Norman, Benjamin, Dembitsky, Walter P., Sussman, Mark A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Integrative
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5709322/
https://ncbi.nlm.nih.gov/pubmed/28980705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1113/JP274980
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados